Hrh Chinese Stock Funds For Three Days Suddenly Turn Into A Buying Power

While HRH Medicine (600 276) annual report just released by data brokers generally lower than expected, so after looking on the stock funds are hesitant to lighten up a two-day, bad digestion, but the Fund will soon be completed, starting from February 10, suddenly the interest in shares thicken, successive exploratory Masukura stock three trading days. Agencies under the password

compass data, the week before the Spring Festival holiday (February 8 -2 12), the Fund and other agencies began probing Masukura HRH medicine, amounted to 80.916 billion yuan of net buying, including buying 32,053.08 million, sold 312,439,200 yuan. In times before, the Fund is still short the stock, on January 4 -2 5 day month, net sold 117,742,300 yuan.

“Innovative company in an important period of transition, and the card imrecoxib music star is expected in the first half of sand to get new drug certificate, dexmedetomidine hydrochloride training set and 5 enzymes aspartate products have production licenses for the company new source. malic acid method m for Nepal, Imatinib mesylate Apa at 5 a class of drugs in clinical phase, while the Ruigelieting is entered into the United States FDA clinical one, which will promote the company from imitation to innovation and development of the important groundwork. huge investment may put some pressure on short-term performance, but will lay the foundation for long-term development, the company into the path of healthy development, we maintain the ‘Recommended’ “, in gold analyst at Sun Liang the report said.

Fund bear to the world holding up HRH Industrial Medicine

Recognized as the industry growth of good medicine, “White Horse Unit” in the fourth quarter of last year’s shock City, HRH was the Fund’s generous Masukura medicine. According to WIND IT data, the end of 2009 a total of 22 funds are heavy stock, the total number of 39195.09 million shares, 17.99% of its float caps of. In contrast, the end of last year’s 9 Total 21 funds are heavy stock, the total number of 9,623.13 million shares, accounting for 15.5% share float caps, holding the number of chain shares the third quarter, an increase of 1546.68.

Ownership is more Societe Generale main trend of investment funds, blue chip growth in the South, Industrial social responsibility, sound and Wa Harvest strategy optimization, were held 1324.5 million, 948.06 million, 929.3 million, 915.09 million and 889.34 shares, the shareholders of the company s 6,7,8,9,10 large circulation.

Sub fund of view, Societe Generale up global position, its two funds?? Societe Generale and Societe Generale investment trends in the social responsibility of holding a total of 2,253.8 million shares. Hua An Fund to 1529.73 million, followed by the company’s strategy of selection and Hua Hua in the small cap growth shares were held by 889.34, and 640.39 million. China Sea Franklin ownership is ranked third, the company’s three largest holding in the company’s funds total 1364.84 million, the potential of its rich portfolio of China, China flexible market and strengthen the income-rich country held 830.85 million shares, respectively A, 530.99 million and 3 million shares.

Unfortunately, the trend this year Hengrui Medicine plain, since the beginning of the cumulative stock price fell 7.62 percent, outperforming the Shanghai index was less than 1 percentage point, many funds did not, what can be accounted for cheap, most positions Societe Generale investment trends in the South blue chip growth, social responsibility, Societe Generale, Castrol sound and optimization strategies such as fund Hua Fukui was 52.98 million yuan, respectively, 37,922,400 yuan, 37,172,000 yuan, 36,603,600 yuan and 35.5736 million yuan.

Ruoshi unpaired fund a two-day haven for wandering suddenly Masukura Fund

Into after 2010, although the index repeated shocks, but these have been selected for the defense of this medicine has not become HRH the Fund’s “safe harbor”; the contrary, some funds began to withdraw from the stock. Compass institutions password data, January 4 -2 12 during the day, led by the agency to fund a total of 111 million siphoned from a stock, of which 1,422,599,000 yuan bought, sold 1,532,249,800 yuan.

Until Hengrui Medicine report released on February 8, the fund short of the situation has not changed. According to agency data, passwords, February 8th day, the agency pulled out slightly from the stock of the 5.2435 million yuan, have brought the stock down 2.48 percent, after a day, funds continue to reduce the 4.4138 million yuan.

2 10 th, the situation suddenly reversed. Agency tentatively day to 2.9343 million yuan Masukura HRH medicine, the successive three days to keep Masukura situation, 11 and 12, respectively, a net inflow of 6.2014 million yuan and 8.6132 million yuan. In the institutional buying pushed up, the stock has risen 7.02% for three days.

Is worth mentioning that the last trading day before Chinese New Year, long and short sides of Traditional Chinese Medicine on HRH intense flame, making the stock the day of the amplitude as high as 10.32%, the share price once Mogao to 51.59 yuan / share. Unfortunately, its long staying power, the stock eventually closed at 48.5 yuan, compared with the previous trading day up 3.41%.